130 related articles for article (PubMed ID: 20947425)
21. Subinhibitory concentrations of phenyl lactic acid interfere with the expression of virulence factors in Staphylococcus aureus and Pseudomonas aeruginosa clinical strains.
Chifiriuc MC; Diţu LM; Banu O; Bleotu C; Drăcea O; Bucur M; Larion C; Israil AM; Lazăr V
Roum Arch Microbiol Immunol; 2009; 68(1):27-33. PubMed ID: 19507624
[TBL] [Abstract][Full Text] [Related]
22. Self-generated diversity produces "insurance effects" in biofilm communities.
Boles BR; Thoendel M; Singh PK
Proc Natl Acad Sci U S A; 2004 Nov; 101(47):16630-5. PubMed ID: 15546998
[TBL] [Abstract][Full Text] [Related]
23. A mathematical model of quorum sensing in a growing bacterial biofilm.
Chopp DL; Kirisits MJ; Moran B; Parsek MR
J Ind Microbiol Biotechnol; 2002 Dec; 29(6):339-46. PubMed ID: 12483476
[TBL] [Abstract][Full Text] [Related]
24. Quorum sensing in biofilms--how to destroy the bacterial citadels or their cohesion/power?
Lazar V
Anaerobe; 2011 Dec; 17(6):280-5. PubMed ID: 21497662
[TBL] [Abstract][Full Text] [Related]
25. Gene expression characteristics of a cystic fibrosis epidemic strain of Pseudomonas aeruginosa during biofilm and planktonic growth.
Manos J; Arthur J; Rose B; Bell S; Tingpej P; Hu H; Webb J; Kjelleberg S; Gorrell MD; Bye P; Harbour C
FEMS Microbiol Lett; 2009 Mar; 292(1):107-14. PubMed ID: 19222585
[TBL] [Abstract][Full Text] [Related]
26. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.
Meluleni GJ; Grout M; Evans DJ; Pier GB
J Immunol; 1995 Aug; 155(4):2029-38. PubMed ID: 7636254
[TBL] [Abstract][Full Text] [Related]
27.
Thi MTT; Wibowo D; Rehm BHA
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33212950
[No Abstract] [Full Text] [Related]
28. Anaerobic culture conditions favor biofilm-like phenotypes in Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
O'May CY; Reid DW; Kirov SM
FEMS Immunol Med Microbiol; 2006 Dec; 48(3):373-80. PubMed ID: 17052266
[TBL] [Abstract][Full Text] [Related]
29. Bacterial biofilms and the pathophysiology of chronic rhinosinusitis.
Al-Mutairi D; Kilty SJ
Curr Opin Allergy Clin Immunol; 2011 Feb; 11(1):18-23. PubMed ID: 21150431
[TBL] [Abstract][Full Text] [Related]
30. Interspecies signalling via the Stenotrophomonas maltophilia diffusible signal factor influences biofilm formation and polymyxin tolerance in Pseudomonas aeruginosa.
Ryan RP; Fouhy Y; Garcia BF; Watt SA; Niehaus K; Yang L; Tolker-Nielsen T; Dow JM
Mol Microbiol; 2008 Apr; 68(1):75-86. PubMed ID: 18312265
[TBL] [Abstract][Full Text] [Related]
31. Rhamnolipids mediate detachment of Pseudomonas aeruginosa from biofilms.
Boles BR; Thoendel M; Singh PK
Mol Microbiol; 2005 Sep; 57(5):1210-23. PubMed ID: 16101996
[TBL] [Abstract][Full Text] [Related]
32. Pseudomonas aeruginosa biofilms: mechanisms of immune evasion.
Alhede M; Bjarnsholt T; Givskov M; Alhede M
Adv Appl Microbiol; 2014; 86():1-40. PubMed ID: 24377853
[TBL] [Abstract][Full Text] [Related]
33. [Investigation of biofilm formation and relationship with genotype and antibiotic susceptibility of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis].
Coban AY; Ciftci A; Onuk EE; Erturan Z; Tanriverdi Cayci Y; Durupinar B
Mikrobiyol Bul; 2009 Oct; 43(4):563-73. PubMed ID: 20084909
[TBL] [Abstract][Full Text] [Related]
34. [Iron uptake and biofilm formation in Pseudomonas aeruginosa].
Yu S; Ma L
Sheng Wu Gong Cheng Xue Bao; 2017 Sep; 33(9):1489-1512. PubMed ID: 28956396
[TBL] [Abstract][Full Text] [Related]
35. The influence of fluid flow on modeling quorum sensing in bacterial biofilms.
Vaughan BL; Smith BG; Chopp DL
Bull Math Biol; 2010 Jul; 72(5):1143-65. PubMed ID: 20146020
[TBL] [Abstract][Full Text] [Related]
36. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C
J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
[TBL] [Abstract][Full Text] [Related]
37. Pseudomonas aeruginosa forms biofilms in acute infection independent of cell-to-cell signaling.
Schaber JA; Triffo WJ; Suh SJ; Oliver JW; Hastert MC; Griswold JA; Auer M; Hamood AN; Rumbaugh KP
Infect Immun; 2007 Aug; 75(8):3715-21. PubMed ID: 17562773
[TBL] [Abstract][Full Text] [Related]
38. Pattern formation in Pseudomonas aeruginosa biofilms.
Parsek MR; Tolker-Nielsen T
Curr Opin Microbiol; 2008 Dec; 11(6):560-6. PubMed ID: 18935979
[TBL] [Abstract][Full Text] [Related]
39. Antipathogenic properties of Lactobacillus plantarum on Pseudomonas aeruginosa: the potential use of its supernatants in the treatment of infected chronic wounds.
Ramos AN; Cabral ME; Noseda D; Bosch A; Yantorno OM; Valdez JC
Wound Repair Regen; 2012; 20(4):552-62. PubMed ID: 22642376
[TBL] [Abstract][Full Text] [Related]
40. Palmitoyl-DL-carnitine is a multitarget inhibitor of Pseudomonas aeruginosa biofilm development.
Wenderska IB; Chong M; McNulty J; Wright GD; Burrows LL
Chembiochem; 2011 Dec; 12(18):2759-66. PubMed ID: 22045628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
